Published in J Urol on January 01, 2006
Upper and lower urinary tract outcomes in adult myelomeningocele patients: a systematic review. PLoS One (2012) 0.91
Congenital causes of neurogenic bladder and the transition to adult care. Transl Androl Urol (2016) 0.79
Urinary considerations for adult patients with spinal dysraphism. Nat Rev Urol (2015) 0.78
Long-term outcomes of urinary tract reconstruction in patients with neurogenic urinary tract dysfunction. Indian J Urol (2013) 0.75
A snapshot of the adult spina bifida patient - high incidence of urologic procedures. Cent European J Urol (2016) 0.75
Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) (2000) 22.00
Exploring feature-based approaches in PET images for predicting cancer treatment outcomes. Pattern Recognit (2009) 3.32
Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene (2000) 2.71
Nocturnal enuresis: a suggestion for a European treatment strategy. Acta Paediatr (1999) 2.70
The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays. Cancer Immunol Immunother (2007) 2.49
Molecular and biochemical heterogeneity of class B carbapenem-hydrolyzing beta-lactamases in Chryseobacterium meningosepticum. Antimicrob Agents Chemother (2000) 2.49
EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees. Ann Rheum Dis (2004) 2.48
Factors determining inpatient satisfaction with care. Soc Sci Med (2002) 2.29
Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation (1996) 2.20
Molecular fingerprinting of Mycobacterium tuberculosis and risk factors for tuberculosis transmission in Paris, France, and surrounding area. J Clin Microbiol (1998) 2.17
The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients. Cancer Res (2000) 2.09
Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin Cancer Res (2001) 2.06
Artificial urinary sphincter in children--voiding or emptying? An evaluation of functional results in 44 patients. J Urol (2008) 2.04
Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries. Ann Rheum Dis (2002) 2.02
Influence of Nitrate and Ammonia on Photosynthetic Characteristics and Leaf Anatomy of Moricandia arvensis. Plant Physiol (1982) 2.02
Pediatric urology. J Pediatr Urol (2010) 2.02
Friedreich's ataxia: point mutations and clinical presentation of compound heterozygotes. Ann Neurol (1999) 2.02
The value of utility: assumptions underlying preferences and quality adjusted life years. J Rheumatol (1999) 2.01
Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer. Breast Cancer Res Treat (1993) 1.97
Cross-cultural adaptation and validation of health status measures. Scand J Rheumatol (1995) 1.93
Abdominal cystic lymphangioma in children: benign lesions that can have a proliferative course. J Pediatr Surg (1996) 1.86
Methodological approaches to shortening composite measurement scales. J Clin Epidemiol (1997) 1.85
Nocturnal enuresis: an international evidence based management strategy. J Urol (2004) 1.85
True hermaphroditism: genetic variants and clinical management. J Pediatr (1994) 1.84
Evolution of the Friedreich's ataxia trinucleotide repeat expansion: founder effect and premutations. Proc Natl Acad Sci U S A (1997) 1.76
Natural history of multiple sclerosis in a population-based cohort. Eur J Neurol (2008) 1.73
Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1. J Natl Cancer Inst (2001) 1.71
Compliance to drug treatment of patients with rheumatoid arthritis: a 3 year longitudinal study. J Rheumatol (1999) 1.70
Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer. Int J Radiat Oncol Biol Phys (1998) 1.70
[Reliable micromethod for determination of the protein content in tissue homogenates]. Acta Biol Med Ger (1975) 1.69
BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood (1994) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Sacral neuromodulation in children with urinary and fecal incontinence: a multicenter, open label, randomized, crossover study. J Urol (2010) 1.67
Expression of the peripheral-type benzodiazepine receptor and apoptosis induction in hepatic stellate cells. Gastroenterology (2001) 1.66
Occupational exposure to blood: search for a relation between personality and behavior. Infect Control Hosp Epidemiol (2000) 1.62
EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer. J Clin Pathol (2009) 1.58
Qualitative and quantitative assessment of C3-receptor reactivities on lymphoid and phagocytic cells. J Immunol (1981) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Bias and precision in visual analogue scales: a randomized controlled trial. Am J Epidemiol (1999) 1.56
Tumour-associated proteolytic factors uPA and PAI-1 and survival in totally resected gastric cancer. Lancet (1994) 1.56
Segregation analysis and variance components analysis of bone mineral density in healthy families. J Bone Miner Res (1995) 1.55
Serial transabdominal amnioinfusion in the management of gastroschisis with severe oligohydramnios. J Pediatr Surg (1996) 1.54
Prevalence of rheumatoid arthritis and spondyloarthropathy in Brittany, France. Société de Rhumatologie de l'Ouest. J Rheumatol (1999) 1.53
Delayed methotrexate pneumonitis in rheumatoid arthritis. J Rheumatol (1991) 1.50
Differential subcellular localization of functionally divergent survivin splice variants. Cell Death Differ (2002) 1.50
Transureteroureterostomy in childhood and adolescence: long-term results in 69 cases. J Urol (2000) 1.47
LPS and TNFalpha induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages. FEBS Lett (1999) 1.46
Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer. Semin Thromb Hemost (1991) 1.46
Scintigraphic screening for renal damage in siblings of children with symptomatic primary vesico-ureteric reflux. BJU Int (2001) 1.46
Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients. Cancer Res (1992) 1.44
A rare complex bladder exstrophy variant. BJU Int (2000) 1.42
Use of spa therapy to improve the quality of life of chronic low back pain patients. Med Care (1998) 1.42
Long-term effects of dextranomer endoscopic injections for treatment of urinary incontinence: an update of a prospective study of 31 patients. J Urol (2006) 1.41
Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40
Isolated spastic paraparesis leading to diagnosis of Friedreich's ataxia. J Neurol Neurosurg Psychiatry (2000) 1.40
Quality of life measurement in children and adolescents: issues, instruments, and applications. J Clin Psychol (2001) 1.40
Increased albuminuria in 4-year-old preterm-born children with normal height. J Pediatr (2012) 1.39
The Groningen Activity Restriction Scale for measuring disability: its utility in international comparisons. Am J Public Health (1994) 1.38
Radiographic scoring methods as outcome measures in rheumatoid arthritis: properties and advantages. Ann Rheum Dis (2001) 1.37
Multicenter study of a commercial, automated polymerase chain reaction system for the rapid detection of Mycobacterium tuberculosis in respiratory specimens in routine clinical practice. Eur J Clin Microbiol Infect Dis (2001) 1.37
Plasminogen activator inhibitor-1 and prognosis in primary breast cancer. J Clin Oncol (1994) 1.36
Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. Cancer Res (1994) 1.36
Early neonatal diagnosis of congenital toxoplasmosis: value of comparative enzyme-linked immunofiltration assay immunological profiles and anti-Toxoplasma gondii immunoglobulin M (IgM) or IgA immunocapture and implications for postnatal therapeutic strategies. J Clin Microbiol (1996) 1.35
Quality of response in different population groups in mail and telephone surveys. Am J Epidemiol (1984) 1.34
Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage. Stroke (1999) 1.34
A review of parameters for the bioelectrical characterization of breast tissue. Ann N Y Acad Sci (1999) 1.34
Fatigue in multiple sclerosis is related to disability, depression and quality of life. J Neurol Sci (2006) 1.32
Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries. Ann Rheum Dis (2003) 1.31
Cellular glycosylphosphatidylinositol-specific phospholipase D regulates urokinase receptor shedding and cell surface expression. J Cell Physiol (1999) 1.30
Conservative treatment by irradiation of epidermoid cancers of the anal canal: prognostic factors of tumoral control and complications. Int J Radiat Oncol Biol Phys (1997) 1.30
Spheroids in radiobiology and photodynamic therapy. Crit Rev Oncol Hematol (2001) 1.29
Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA). J Biol Chem (1991) 1.29
Inappropriate liver transplantation in a child with Alpers-Huttenlocher syndrome misdiagnosed as valproate-induced acute liver failure. Pediatr Transplant (2000) 1.27
Prevalence of spondyloarthropathies in France: 2001. Ann Rheum Dis (2005) 1.27
Congenital anterior urethrocutaneous fistula associated with a stenosis of the bulbar urethra in the context of high anorectal malformation without fistula. J Plast Reconstr Aesthet Surg (2008) 1.26
Meiotic instability of human minisatellite CEB1 in yeast requires DNA double-strand breaks. Nat Genet (1999) 1.26
uPA and PAI-1 in breast cancer: review of their clinical utility and current validation in the prospective NNBC-3 trial. Adv Clin Chem (2008) 1.25
A novel mechanism of action for v-ErbA: abrogation of the inactivation of transcription factor AP-1 by retinoic acid and thyroid hormone receptors. Cell (1991) 1.25
Cancer in systemic sclerosis. Arthritis Rheum (1993) 1.24
A comparison of agreement and sensitivity to change between AIMS2 and a short form of AIMS2 (AIMS2-SF) in more than 1,000 rheumatoid arthritis patients. J Rheumatol (2000) 1.24
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23
Xanthogranulomatous pyelonephritis in childhood. J Pediatr Surg (2001) 1.23
Urokinase-type plasminogen activator antigen and early relapse in breast cancer. Lancet (1989) 1.22
Cystic rectal duplication: a rare cause of neonatal intestinal obstruction. Pediatr Surg Int (1997) 1.22
Efficient transmission of two different sheep scrapie isolates in transgenic mice expressing the ovine PrP gene. J Virol (2001) 1.21
A catalytic cycle for the asymmetric synthesis of epoxides using sulfur ylides. J Org Chem (2001) 1.21
Efficacy studies on a canarypox-rabies recombinant virus. Vaccine (1991) 1.20
Self-administered questionnaire compared with interview to assess past-year physical activity. Med Sci Sports Exerc (2000) 1.20
Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19
Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients. J Clin Oncol (1998) 1.19
Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group. Scand J Infect Dis (1998) 1.19
Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 1.19
Prevalence of impairments, disabilities, handicaps and quality of life in the general population: a review of recent literature. Bull World Health Organ (2001) 1.19
Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis. Cancer Res (2001) 1.19
A minority of 46,XX true hermaphrodites are positive for the Y-DNA sequence including SRY. Hum Genet (1992) 1.18
MTT assays allow quick and reliable measurement of the response of human tumour cells to photodynamic therapy. Eur J Cancer (1992) 1.18